synbiobeta.com synbiobeta.com

DMC and Conagen Partner for Commercial Manufacturing of L-alanine

21 April 2021 – DMC Biotechnologies and Conagen Inc. have entered into a manufacturing agreement for the commercial production of DMC’s first product, L-alanine. L-alanine is a naturally occurring amino acid used widely in homecare products, human nutrition, and pharmaceutical applications. DMC’s fermentation technology enables L-alanine to be produced with attractive economics as part of a regional supply chain with increased...

synbiobeta.com synbiobeta.com

Nēsos receives FDA Breakthrough Device Designation for its disease modifying digital therapeutic for Rheumatoid Arthritis

REDWOOD CITY, Calif. (April 22, 2021) Nēsos, the company developing disease-modifying digital therapeutics for inflammation-mediated disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its digital therapeutic for patients with rheumatoid arthritis (RA) who have had an inadequate response or intolerance to disease-modifying anti-rheumatic drugs (DMARDs). The...

synbiobeta.com synbiobeta.com

TetraScience Secures $80 Million Series B and Accelerates Roll Out of the World’s Only Open R&D Data Cloud for Scientific Discovery

Insight Partners and Alkeon Capital credit the company with category and revenue leadership in the $300B experimental data cloud market BOSTON, April 15, 2021 /PRNewswire/ — TetraScience, the world’s only cloud-native and open R&D Data Cloud for scientific discovery, announced today that it has closed its $80 million Series B to capitalize on the unprecedented demand for its category-defining industry data cloud. Co-led by...

synbiobeta.com synbiobeta.com

New Coalition Dedicated To Fostering American Synthetic Biology Manufacturing Launched Today

The SynBio Coalition, Backed by Three Industry Leaders, Says Innovation is Key for American Global Leadership, Job Creation, Greater Security, and the New Green Economy; Pledges to Work with Government, Industry WASHINGTON, April 14, 2021 /PRNewswire/ — Today, three leading synthetic biology companies announced the launch of the Synthetic Biology (SynBio) Coalition (www.synbioco.com) to promote investment and support for the...

synbiobeta.com synbiobeta.com

Benchling Raises $200M Series E To Accelerate Biotech R&D

Led by Sequoia, new funding will fuel life sciences cloud leader’s global growth and product expansion SAN FRANCISCO, April 14, 2021 /PRNewswire/ — Benchling, the leading life sciences R&D cloud, has raised $200 million in Series E funding led by Sequoia Capital Global Equities and joined by Altimeter Capital, Byers Capital and Elad Gil. Existing investors participated, including Thrive Capital, Benchmark, Menlo Ventures,...